Enfortumab Vedotin Biosimilar - Research Grade
Product Specifications
Background
Enfortumab vedotin-ejfv is an ADC consisting of a Nectin-4-directed antibody and Monomethyl auristatin E (MMAE), suitable for adult patients with locally advanced or metastatic urothelial carcinoma, or who have received programmed cell death protein 1 (PD-1) inhibitor or programmed cell death ligand 1 (PD-L1) inhibitor therapy or neoadjuvant/adjuvant platinum-based chemotherapy for locally advanced or metastatic cancer.
Product Name Alternative
MMAE
Host
CHO Cells
Reactivity
Human
Target
Nectin-4
Isotype
IgG1
Applications
Functional Assays
Concentration
1mg/mL
Purity
>90% by SDS-PAGE
Shipping Conditions
Room Temp
Storage Conditions
This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Formulation
25mM histidine, 8% sucrose, 0.01% Tween80 (pH6.2)
Applications Notes
Reconstitute with sterile, distilled water to a final concentration of 1 mg/ml. Gently shake to solubilize completely. Do not vortex.
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL313520V 500 µL Each
DDX23 Human shRNA Lentiviral Particle (Locus ID 9416)
Sign In for Pricing
View Details 
MBS961589 Inquire
Recombinant Bovine Transmembrane protein 80 (TMEM80)
Sign In for Pricing
View Details